About US
About US
Introduction
Our Value
History
Contact Us
Join Us
Patients
Patients
Patients
Peripheral Arterial Disease
Peripheral Arteriosclerosis
Peripheral Venous Disease
Varicosity
Peripheral Arterial Disease
Peripheral Venous Disease
Peripheral Arteriosclerosis
Varicosity
Professional Medical Solutions
Professional Medical Solutions
Products
Peripheral Artery
PTA Catheter
ATK DCB Dilatation catheter
BTK DCB Dilatation Catheter
Support Catheter
Peripheral Cone-shaped Balloon Dilation Catheter
Peripheral Vein
Peripheral Vascular Aspiration System
Endovenous RF Closure System
Second Generation Peripheral Vascular Aspiration S
Maintenance Of Arteriovenous Fistula Access
DCB Dilatation Catheter for Hemodialysis Access
Peripheral Scoring Balloon Dilatation Catheter
Neurovascular
Endocranial Balloon Dilatation Catheter
Coronary Artery
Coronary Artery Balloon Dilatation Catheter
RT-Zero Coronary Artery Balloon Dilatation Cathete
Vericor-14 Microtubule
Coronary High-pressure Balloon
Coronary CTO Retrograde Micro-Catheter
Academic
Peripheral Artery
Peripheral Vein
Maintenance Of Arteriovenous Fistula Access
Neurovascular
Coronary Artery
PTA Catheter
ATK DCB Dilatation catheter
BTK DCB Dilatation Catheter
Support Catheter
Peripheral Cone-shaped Balloon Dilation Catheter
Peripheral Vascular Aspiration System
Endovenous RF Closure System
Second Generation Peripheral Vascular Aspiration S
DCB Dilatation Catheter for Hemodialysis Access
Peripheral Scoring Balloon Dilatation Catheter
Endocranial Balloon Dilatation Catheter
Coronary Artery Balloon Dilatation Catheter
RT-Zero Coronary Artery Balloon Dilatation Cathete
Vericor-14 Microtubule
Coronary High-pressure Balloon
Coronary CTO Retrograde Micro-Catheter
News
News
Corporate News
R&D Progress
Investor Relations
News
All
Corporate News
R&D Progress
Corporate News
2024-03-26
Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures
2022-12-17
Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them
Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures
2024-03-26
Acotec and Boston Scientific Sign Master Collaboration Agreement and Master Service Agreement
2023-07-20
Acotec and Boston Scientific Sign Memorandum of Understanding
2023-06-19
Acotec Reports 2022 Annual Results: full-year revenue of $396 million, up 30% year-over-year
2023-04-13
Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them
2022-12-17
先瑞达2022中期业绩发布:营收1.75亿元,同比增长25%,增长点多元化
2022-08-27
先瑞达发布2021年业绩报告:全年营收3.04亿元,同比增长56.6%,调整后净利润同比增长140.4%
2022-03-30
道阻且长 行则将至 | 先瑞达2021年终盘点
2022-01-30
先瑞达披露2021年年度经营数据预测:年度营收和毛利较去年同比实现大幅增长
2022-01-24
先瑞达荣膺格隆汇“年度最具创新力IPO”奖
2021-12-15
Load more information